Senate Democrats urge Trump to walk back Nvidia, AMD deal

Senate Democrats are urging the Trump administration to reverse a controversial deal permitting Nvidia and AMD to sell advanced AI chips to China, conditioned on a 15% revenue share. Lawmakers argue this arrangement poses significant national security risks by bolstering a strategic adversary's technological capabilities and potentially violates federal law regarding export license fees. While Nvidia defends the sales as beneficial for U.S. AI leadership, the White House has indicated similar revenue-sharing agreements might be pursued with other companies, highlighting an evolving and legally ambiguous approach to critical technology exports.

Analysis

Nvidia (NVDA) and Advanced Micro Devices (AMD) are facing significant political and legal headwinds following a deal with the Trump administration to resume AI chip sales to China. The agreement, which permits the export of Nvidia's H20 and AMD's MI308 chips in exchange for a 15% revenue share, has drawn sharp criticism from senior Senate Democrats who argue it undermines U.S. national security by providing a key adversary with critical technology. The senators contend this arrangement violates the intent of export control laws and trades a strategic competitive advantage for what is effectively a sales commission. This political opposition, reflected in the strongly negative sentiment score (-0.7 for both tickers), introduces substantial regulatory risk and uncertainty around the durability of these sales licenses. While Nvidia defends the deal by stating its H20 chip would not enhance military capabilities, the legal foundation of the 15% fee is also precarious, as it could be challenged as an illegal export license fee or an unconstitutional export tax. The White House's indication that this revenue-sharing model could be expanded to other companies signals a potential, albeit controversial, shift in U.S. technology export policy, creating a precedent that could impact the entire semiconductor industry.

Key Decisions for Investors

• Investors in Nvidia and AMD should view the announced China sales as carrying high regulatory risk, as intense political opposition could lead to a sudden reversal of the export licenses, jeopardizing this revenue stream.
• The 15% revenue sharing agreement must be factored into financial models as a direct tax on China sales for the H20 and MI308 chips, which will materially impact gross margins and net profitability from this specific market segment.
• Monitor any legal challenges to the deal's structure, as a ruling that deems the 15% fee an illegal tax would immediately invalidate the agreements and halt a key growth avenue for both companies in the Chinese market.
• Consider the broader sector implications, as the precedent set by this deal could introduce a new layer of regulatory costs and uncertainty for any U.S. technology firm seeking export licenses for sales to geopolitical competitors.